Scopus BioPharma Inc (SCPS)
0.0021
0.00 (0.00%)
USD |
OTCM |
May 22, 16:00
Scopus BioPharma Cash from Investing (Quarterly): 0.00 for June 30, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | -0.0016M |
| December 31, 2021 | 0.00 |
| September 30, 2021 | -0.002M |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | -0.0007M |
| September 30, 2019 | -0.0013M |
| June 30, 2019 | -0.0023M |
| March 31, 2019 | |
| June 30, 2018 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-0.0023M
Minimum
Jun 2019
--
Maximum
Sep 2020
-0.0005M
Average
--
Median
Sep 2020
Cash from Investing (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 1.068M |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | 1.00M |
| Theriva Biologics Inc | 0.00 |
| Oragenics Inc | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.009M |
| Cash from Financing (Quarterly) | -0.0447M |
| Free Cash Flow | -3.043M |
| Free Cash Flow Per Share (Quarterly) | -0.0254 |